Cortico-cognition coupling in treatment resistant schizophrenia

被引:6
|
作者
Syeda, Warda T. [1 ]
Wannan, Cassandra M. J. [1 ]
Merritt, Antonia H. [1 ]
Raghava, Jayachandra M. [2 ,6 ]
Jayaram, Mahesh [1 ,5 ]
Velakoulis, Dennis [1 ]
Kristensen, Tina D. [2 ,3 ]
Soldatos, Rigas Filippos [1 ,9 ]
Tonissen, Shane [1 ]
Thomas, Naveen [1 ,5 ]
Ambrosen, Karen S. [2 ,3 ]
Sorensen, Mikkel E. [2 ,3 ]
Fagerlund, Birgitte [2 ,3 ]
Rostrup, Egill [2 ,3 ]
Glenthoj, Birte Y. [2 ,3 ,4 ]
Skafidas, Efstratios [1 ]
Bousman, Chad A. [1 ,7 ]
Johnston, Leigh A. [10 ]
Everall, Ian [8 ]
Ebdrup, Bjorn H. [1 ,2 ,3 ,4 ]
Pantelis, Christos [1 ,2 ,3 ,4 ,5 ,11 ]
机构
[1] Univ Melbourne & Melbourne Hlth, Melbourne Neuropsychiat Ctr, Dept Psychiat, Parkville, Vic, Australia
[2] Univ Copenhagen, Ctr Neuropsychiat Schizophrenia Res, Glostrup, Denmark
[3] Univ Copenhagen, Ctr Clin Intervent & Neuropsychiat Schizophrenia R, Mental Hlth Ctr Glostrup, Glostrup, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[5] Sunshine Hosp, MidWest Area Mental Hlth Serv, St Albans, Vic, Australia
[6] Rigshospitalet, Dept Clin Physiol Nucl Med & PET, Funct Imaging Unit, Glostrup, Denmark
[7] Univ Calgary, Dept Med Genet Psychiat & Physiol & Pharmacol, Calgary, AB, Canada
[8] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
[9] Natl & Kapodistrian Univ Athens Med Sch, Eginit Hosp, Dept Psychiat 1, Athens, Greece
[10] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia
[11] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia
基金
英国医学研究理事会;
关键词
Partial least squares correlation; Treatment-resistant schizophrenia; Cognition; Brain structure; MRI; WORKING-MEMORY; ATTENTION; TUTORIAL; CORTEX;
D O I
10.1016/j.nicl.2022.103064
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Background: Brain structural alterations and cognitive dysfunction are independent predictors for poor clinical outcome in schizophrenia, and the associations between these domains remains unclear. We employed a novel, multiblock partial least squares correlation (MB-PLS-C) technique and investigated multivariate cortico-cognitive patterns in patients with treatment-resistant schizophrenia (TRS) and matched healthy controls (HC). Method: Forty-one TRS patients (age 38.5 +/- 9.1, 30 males (M)), and 45 HC (age 40.2 +/- 10.6, 29 M) underwent 3T structural MRI. Volumes of 68 brain regions and seven variables from CANTAB covering memory and executive domains were included. Univariate group differences were assessed, followed by the MB-PLS-C analyses to identify group-specific multivariate patterns of cortico-cognitive coupling. Supplementary three-group analyses, which included 23 non-affected first-degree relatives (NAR), were also conducted. Results: Univariate tests demonstrated that TRS patients showed impairments in all seven cognitive tasks and volume reductions in 12 cortical regions following Bonferroni correction. The MB-PLS-C analyses revealed two significant latent variables (LVs) explaining > 90% of the sum-of-squares variance. LV1 explained 78.86% of the sum-of-squares variance, describing a shared, widespread structure-cognitive pattern relevant to both TRS patients and HCs. In contrast, LV2 (13.47% of sum-of-squares variance explained) appeared specific to TRS and comprised a differential cortico-cognitive pattern including frontal and temporal lobes as well as paired associates learning (PAL) and intra-extra dimensional set shifting (IED). Three-group analyses also identified two significant LVs, with NARs more closely resembling healthy controls than TRS patients. Conclusions: MB-PLS-C analyses identified multivariate brain structural-cognitive patterns in the latent space that may provide a TRS signature.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Handbook of treatment-resistant schizophrenia
    Volavka, J.
    ACTA PSYCHIATRICA SCANDINAVICA, 2013, 128 (01) : 102 - 102
  • [32] Treatment resistant schizophrenia and electroconvulsive therapy
    Duarte, M.
    Agostinho, C.
    Alves, R.
    Goncalves, F.
    Ponte, A.
    Baptista, A.
    Cunha, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S567 - S567
  • [33] Use of Aripiprazole in treatment resistant schizophrenia
    Hughes, D.
    Morcos, M.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (08) : 927 - 928
  • [34] THE GENOMICS OF HIGHLY TREATMENT RESISTANT SCHIZOPHRENIA
    Farrell, Martilias
    Lichtenstein, Maya
    Crowley, James
    Filmyer, Dawn
    Lazaro-Munoz, Gabriel
    Shaughnessy, Rita
    Mackenzie, Ian R.
    Hirsch-Reinshagen, Veronica
    Stowe, Robert
    Evans, James
    Berg, Jonathan
    Szatkiewicz, Jin
    Josiassen, Richard
    Sullivan, Patrick F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S1006 - S1007
  • [35] Perphenazine in Treatment-Resistant Schizophrenia
    Hower, Michael R.
    Karlapati, Surya Kumar
    Bachu, Anil K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [36] Galantamine for treatment-resistant schizophrenia
    Allen, TB
    McEvoy, JP
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (07): : 1244 - 1245
  • [37] Treatment-resistant schizophrenia.
    Lublin, H
    NORDIC JOURNAL OF PSYCHIATRY, 1997, 51 : 9 - 23
  • [38] Pharmacotherapy for treatment-resistant schizophrenia
    Mcilwain, Meghan E.
    Harrison, Jeff
    Wheeler, Amanda J.
    Russell, Bruce R.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 135 - 149
  • [39] Clozapine, GABAB, and the Treatment of Resistant Schizophrenia
    Daskalakis, Z. J.
    George, T. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (04) : 442 - 446
  • [40] CBT for treatment-resistant schizophrenia
    Kar, N
    Dasi, R
    BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 87 - 87